Comparative Pharmacology
Head-to-head clinical analysis: ATROPEN versus ATROPINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ATROPEN versus ATROPINE.
ATROPEN vs ATROPINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Competitive antagonist of muscarinic acetylcholine receptors (M1, M2, M3, M4, M5). Blocks parasympathetic nerve impulses, leading to increased heart rate, bronchodilation, decreased secretions, and mydriasis.
Competitive antagonist of muscarinic acetylcholine receptors (M1, M2, M3, M4, M5), blocking the effects of acetylcholine and other cholinergic agonists. Inhibits vagal activity, increases heart rate, reduces secretions, and relaxes smooth muscle.
0.5 to 1 mg IV/IM/SC every 3 to 5 minutes as needed; maximum 3 mg total. For bradycardia: 0.5 mg IV every 3-5 minutes to a maximum of 3 mg. For organophosphate poisoning: 2 mg IV/IM initially, then 2 mg every 5-10 minutes until atropinization.
0.5-1 mg IV/IM/SC every 3-5 minutes as needed, up to a total of 3 mg (adults). For preoperative use, 0.4-0.6 mg IM/IV 30-60 minutes before anesthesia.
None Documented
None Documented
Clinical Note
moderateBenzatropine + Haloperidol
"The metabolism of Haloperidol can be decreased when combined with Benzatropine."
Clinical Note
moderateBenzatropine + Fluconazole
"The metabolism of Fluconazole can be decreased when combined with Benzatropine."
Clinical Note
moderateBenzatropine + Clotrimazole
"The metabolism of Clotrimazole can be decreased when combined with Benzatropine."
Clinical Note
moderateBenzatropine + Dronedarone
Terminal half-life ~2-3 hours in adults; prolonged in elderly and infants due to reduced clearance.
2-4 hours (terminal); prolonged in elderly and neonates; clinically requires dosing every 4-6 hours
Renal: ~50% unchanged; hepatic metabolism (hydrolysis) accounts for ~30-40%; fecal: <5%.
Renal (30-50% unchanged; remainder as inactive metabolites via hydrolysis and glucuronidation); 50-70% of a dose renally excreted as metabolites; <5% fecal
Category C
Category C
Anticholinergic Agent
Anticholinergic Agent
"The metabolism of Dronedarone can be decreased when combined with Benzatropine."